9-21-20 Allen Cardoza interviews Matt Gdovin, PhD & Tom RobertsAccording the National Cancer Society, in 2019 cancer killed a staggering 606,000 people in the U.S.On the forefront, Vitanova Biomedical (VNB) is developing the most effective therapy yet to destroy multiple cancers with no damage to surrounding cells or side effects. Light-Activated Acidosis (LAIA), uses a focused beam of light to activate a targeted drug injected into the tumor. Once activated, this drug causes the cancer cell to become very acid on the inside triggering rapid apoptosis (cell death). LAIA therapy has proven capable of killing up to 95 percent of cancer cells including two breast cancers (MCF-7) and the very aggressive triple negative breast cancer (MDA-MB-231), two types of prostate cancers (LNCaP and 22RV1), and a pancreatic cancer (BxPC3). Dr. Matt Gdovin, founder, states VNB’s LAIA therapy holds great promise as an alternative to the current standard of care treatments, CEO, Tom Roberts share that VNB was recently awarded a competitive National Science Foundation SBIR Program Phase I grant and together, with other equipment and funding partnerships will advance VNB’s LAIA therapy from laboratory bench to an FDA submission….and ultimately to patients across the world.  

Ver todos los episodios